| Schedule of Restructuring and Related Costs |
Other restructuring charges under the Restructuring Plan recorded by the Company consisted of the following (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | | | | | | | | | Severance and employee benefit costs | $ | 1,969 | | | $ | 4,218 | | | 7,065 | | | 4,723 | | | Impairment of long-lived assets | 2,108 | | | 348 | | | 2,374 | | | 348 | | Total other restructuring charges (1) | $ | 4,077 | | | $ | 4,566 | | | $ | 9,439 | | | $ | 5,071 | |
(1) Restructuring charges of $2.9 million and $1.2 million are included in Research and development and Selling, general, and administrative expenses, respectively, for the three months ended June 30, 2026, and restructuring charges of $1.6 million and $3.0 million are included in Research and development and Selling, general, and administrative expenses, respectively, for the three months ended June 30, 2025. Restructuring charges of $6.7 million and $2.7 million are included in Research and development and Selling, general, and administrative expenses, respectively, for the six months ended June 30, 2026, and restructuring charges of $1.6 million and $3.5 million are included in Research and development and Selling, general, and administrative expenses, respectively, for the six months ended June 30, 2025.
|
| Summary of the Activity within the Accrued Severance and Employee Benefits Liability |
The following table summarizes the activity within the accrued severance and employee benefits liability, which is included in Accrued expenses in the Company’s consolidated balance sheets as of June 30, 2026 (in thousands): | | | | | | | | | | | Amount | | | | Balance at December 31, 2025 | $ | 670 | | | | | Severance and employee benefit costs | 7,065 | | | | Cash payments | (6,966) | | | | | Balance at June 30, 2026 | $ | 769 | | | |
|